Insider Trading & Ownership of New Enterprise Associates 17, L.P.

Location
Timonium, MD
Summary
The estimated value of insider holdings of New Enterprise Associates 17, L.P. is at least $367,167,216 dollars as of 12 Mar 2026. New Enterprise Associates 17, L.P. is the 10%+ Owner of SpyGlass Pharma, Inc. and owns shares of SpyGlass Pharma, Inc. (SGP) stock worth about $167.96M. New Enterprise Associates 17, L.P. is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146.15M. New Enterprise Associates 17, L.P. is the 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $38.64M. New Enterprise Associates 17, L.P. is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $14.42M.
Signature
/s/ Zachary Bambach, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when New Enterprise Associates 17, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of New Enterprise Associates 17, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SGP SpyGlass Pharma, Inc. 10%+ Owner $167,955,108 09 Feb 2026
GLUE Monte Rosa Therapeutics, Inc. 10%+ Owner $146,153,662 28 Jun 2021
MBX MBX Biosciences, Inc. 10%+ Owner $38,638,855 16 Sep 2024
KRRO Korro Bio, Inc. 10%+ Owner $14,419,591 +$2,300,881 +19% 10 Mar 2026
NEUE NeueHealth, Inc. Director, 10%+ Owner $0 -$1,890 -100% 02 Oct 2025

Insider Transactions Reported by New Enterprise Associates 17, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.